Immunomodulating drugs such as inhibitors of tumor necrosis factor-α (etanercept) [5] and intravenous immunoglobulins [6] have been used in treating refractory asthma; however, no consistent improvement in lung function has been demonstrated. Here, TNF is linked to asthma.